Experience
CMM has operated as a clinical research site for 12 years and has conducted 20 clinical trials. The research team's experience dates back to 2005. The site has enrolled 287 participants since 2019. Public information is presented in aggregate and does not identify sponsors, CROs or protocol numbers.
| Year | Indication | Phase / type | Enrolled |
|---|---|---|---|
| 2019 | Erectile dysfunction | Phase III | 120 |
| 2020 | Menopause | Phase III | 41 |
| 2020 | Erectile dysfunction | Pivotal study | 31 |
| 2021 | Crohn’s disease | Phase II | 1 |
| 2021 | Endometriosis | Phase IIa | 1 |
| 2021 | Erectile dysfunction | Phase IV | 19 |
| 2022 | Menopause | Phase IIIb | 11 |
| 2023 | Contraception | Pivotal study | 16 |
| 2024 | Dysmenorrhea | Phase III | 16 |
| 2025 | Smoking cessation | Phase III | 13 |
| 2025 | Herpes labialis | Phase III | 18 |
Therapeutic experience
- Gastroenterology: Crohn’s disease, ulcerative colitis.
- Pulmonology: COPD, allergies, smoking.
- Sexual medicine: erectile dysfunction, premature ejaculation.
- Gynecology: contraception, menopause, endometriosis.
- Other: herpes labialis.
Recruitment experience
CMM has experience in both high-enrollment trials and studies involving narrowly defined populations. Recruitment potential is assessed individually. Public information is presented in aggregate form and does not disclose sponsor names, CROs, protocol numbers or other confidential information.